Skip to main content

Table 2 Responders versus non-responders

From: Patients profiling for Botox® (onabotulinum toxin A) treatment for migraine: a look at white matter lesions in the MRI as a potential marker

 

Responders

Non-responders

p-value

 

to Botox®

to Botox®

 

Age (mean)

47

52

0.07 ns

Age at onset (mean)

21

21

0.912 ns

Gender (m/f) %

15/85

23/77

0.265 ns

Lifetime migraine (years)

26

31

0.255 ns

Chronic migraine %

66

62.5

0.708 ns

Aura %

60

52

0.402 ns

WML %

55

50

0.579 ns

WML small (mean per person)

2.3

2.9

0.897 ns

WML medium (mean per person)

0.2

0.2

0.875 ns

WML large (mean per person)

0.02

0.03

0.750 ns